Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases:... by Xing He, Yaorong Peng, Zhenyu Zhou, Wenbin Li

Get full text

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer by Wenbin Li, Yue Zhu, Kelin Zhang, Xianhuan Yu, Haoming Lin, Wenrui Wu, Yaorong Peng, Jian Sun

Get full text

circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324 by Hanqin Weng, Lexiang Zeng, Linhui Cao, Tao Chen, Yanshan Li, Yunxiuxiu Xu, Yaorong Peng, Yibiao Ye

Get full text

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters by Heyun Zhang, Zhangyu Zheng, Rongqin Zhang, Yongcong Yan, Yaorong Peng, Hua Ye, Lehang Lin, Junyao Xu, Wenbin Li, Pinbo Huang

Get full text

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters by Heyun Zhang, Zhangyu Zheng, Rongqin Zhang, Yongcong Yan, Yaorong Peng, Hua Ye, Lehang Lin, Junyao Xu, Wenbin Li, Pinbo Huang

Get full text

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer by Xing He, Yaorong Peng, Gui He, Huilin Ye, Liqiang Liu, Qixian Zhou, Juanyi Shi, Sha Fu, Jie Wang, Zhenyu Zhou, Wenbin Li

Get full text

Correction to: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer by Xing He, Yaorong Peng, Gui He, Huilin Ye, Liqiang Liu, Qixian Zhou, Juanyi Shi, Sha Fu, Jie Wang, Zhenyu Zhou, Wenbin Li

Get full text